{"anticipatedPostingDate":"2027-06","denomUnitsSelected":"Participants","description":"CR with IDH1 MC is defined as a response of CR where there is no evidence of the IDH1 mutation by molecular techniques to below the level of detection (0.02%-0.04%) for ≥1 on-treatment time point. A CMH test will be used to compare the rate of CR between 2 treatment arms.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 52 months","title":"Percentage of Participants With CR With IDH1 Mutation Clearance (MC)","type":"SECONDARY"}